HC Wainwright & Co. reiterates Buy rating on Palisade Bio, $7 price target
HC Wainwright & Co. reiterated their Buy rating on Palisade Bio's stock with a price target of $7.00.The price target implies an upside of 314.2% from the Sep 22 close of $1.69.Key takeaways from the analyst notePositive Early Clinical Results: Palisade Bio's PALI-2108 demonstrated promising early…